title: Response to commentary by Dixon and Silman on the systematic review and meta-analysis by Bongartz et al.
authors.forename: Eric L
authors.initials: EL
authors.lastname: Matteson
authors.forename: Tim
authors.initials: T
authors.lastname: Bongartz
authors.forename: Alex J
authors.initials: AJ
authors.lastname: Sutton
authors.forename: Iain
authors.initials: I
authors.lastname: Buchan
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000453:epidemiology* / Q000628:therapy*; D006801:Humans; D007239:Infections / Q000453:epidemiology*; D015201:Meta-Analysis as Topic; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha